# ASPIRE BIOPHARMA HLDGS INC (ASBPW)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ASBPW/

- Reporting holders: 1
- Reported value: $0

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Investors Research Corp](https://holderbook.com/funds/1730630-investors-research-corp/) | $0 | 10 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 1 | $0 |
| Q2 2026 | 30 | $154.8K |
| Q1 2026 | 28 | $129.1K |
| Q4 2025 | 27 | $146.6K |
| Q3 2025 | 29 | $256.3K |
| Q2 2025 | 31 | $420.4K |
| Q1 2025 | 30 | $685.4K |

